FAP and neoplasm: The uptake of various tracers targeting FAP-labeled fibroblast-activating protein inhibitors (FAPI) is high in most tumors but low in normal tissues, such as in the brain and abdomen, resulting in a good tumor-to-background ratio (TBR) and good tumor delineation.